drugset / Trial / NCT00486174
Methylene Blue in Sepsis: A Randomized Controlled Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate whether the addition of Methylene Blue to the standard treatment of septic shock will reduce vasopressor requirements
Timeline
- Start
- 2007-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylene Blue | Diagnostic / imaging agent | 2 mg/kg | — |